MedDataX Logo

Translational Cancer Observational Protocol

NCT ID: NCT06169436

Last Updated: 2023-12-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-07-17

Study Completion Date

2064-07-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observational study on relapse occurrence and on the quality of life in patients who underwent nephroureterectomy surgery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Monocentric prospective and retrospective observational study on the quality of life and on the pathological status in patients who underwent nephroureterectomy surgery. Oncological, psychological, sexual and quality of life-related data will be collected within a specifically created database that will allow us an easy and secure data extraction for the statistical analysis required by the clinical trial in terms of oncological relapse, clinical progression and improve the assistance and therapeutic strategy for each patient. Retrospective data for patients who underwent surgery between 1987 and today will be available in the form of clinical report stored in the hospital archives.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Urinary Tract Urothelial Carcinoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Upper Urinary Tract Urothelial Carcinoma Nephroureterectomy surgery Relapse Quality of life Diagnosis and Treatment strategies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental

Patients with upper urinary tract urothelial cancer who underwent nephroureterectomy surgery

Nephroureterectomy

Intervention Type PROCEDURE

Removal of cancer mass by urether and kidney complete resection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nephroureterectomy

Removal of cancer mass by urether and kidney complete resection.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
* Upper tract urothelial cancer diagnosis
* Indication to cancer removal through nephroureterectomy surgery
* Ability to read and sign the informed consent

Exclusion Criteria

* Age \< 18 years
* Absence of upper tract urothelial cancer
* Inability to read and sign the informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS San Raffaele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Francesco Montorsi

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francesco Montorsi, MD

Role: PRINCIPAL_INVESTIGATOR

IRCCS Ospedale San Raffaele

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Ospedale San Raffaele

Milan, MI, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Francesco Montorsi, MD.

Role: CONTACT

Phone: 02 2643 7286

Email: [email protected]

Francesco Fiorio, MSC

Role: CONTACT

Phone: 02 2643 6268

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Francesco Fiorio, MSC

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014 - Transizionali

Identifier Type: -

Identifier Source: org_study_id